Arca
Skip to content

Osteoarthritis

Drug research and approvals for osteoarthritis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 604 studies of osteoarthritis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 48 drug trials for it since 2013.

  • Recruiting worldwide: 604
  • Trials authorized in Canada: 48
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 604 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

The 10 newest of 48; search them all in Canada trials
Sep 14, 2026A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of once-weekly berobenatide in adults with knee osteoarthritis…BEROBENATIDE (PF-08653944)PfizerPending
Aug 20, 2026A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of once-monthly berobenatide in adults with knee osteoarthritis…BEROBENATIDE (PF-08653944, MET097)PfizerPending
Feb 25, 2026Master protocol: a master protocol for phase 3 randomized, double-blind, placebo-controlled studies to investigate the efficacy and safety of once weekly…ELORALINTIDE (LY3841136)Eli LillyOngoing
Feb 19, 2026Efficacy and safety of nnc0487-0111 s.c. once-weekly in participants with overweight or obesity, and knee osteoarthritis (amaze 5)NNC0487-0111Novo NordiskOngoing
Feb 19, 2026Efficacy and safety of nnc0487-0111 s.c. once-weekly in participants with overweight or obesity, and knee osteoarthritis (amaze 6)NNC0487-0111Novo NordiskOngoing
Sep 12, 2025A phase 3 study to investigate the efficacy and safety of orforglipron once daily in participants who have obesity or overweight and osteoarthritis of the…ORFORGLIPRON (LY3502970)Eli LillyOngoing
Aug 29, 2025Single dose parallel comparative bioavailability study of triamcinolone hexacetonide following intra-articular administration of a single dose injection of…CINGAL (TRIAMCINOLONE HEXACETONIDE -HYALURONIC ACID) / ARISTOSPAN…Anika TherapeuticsOngoing
Jul 17, 2025Preliminary dosimetry study of homogeneous 117msn hydroxide micriparticles for radiosynoviorthesis in pateints with olsteoarthritis of the kneeHOMOGENOUS 117MSN HYDROXIDE MICROPARTICLES (HTM)SERENE, LLCPending
Jul 10, 2025A multicenter, randomized, double-blind, placebo-controlled, phase 2 study to evaluate the efficacy and safety of vent-02 in adult participants with painful…VENT-02VENTUS THERAPEUTICS U.SPending
Jun 20, 2025Multiprofen-cc to reduce pain in hand arthritis (mrp-hand): a crossover randomized controlled trialAMITRIPTYLINE-BACLOFEN-KETOPROFEN-LIDOCAINETHE RESEARCH INSITITUTE OF ST. JOSEPH'S HAMILTONOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.